Fluid Teardowns — Nº 016
One patented molecule.
Sold by the people
you trust with your hair.
Olaplex didn't sell shampoo — it sold a patented, unpronounceable molecule that repairs hair bonds, and it let hairstylists sell it for them first. That salon credibility plus a numbered product system built a brand that IPO'd at a roughly $15 billion valuation. Here's the teardown — cliff and all.
Olaplex is two lessons in one: how to build a category-defining brand, and how quickly that brand can wobble. The build was brilliant. Instead of another shampoo, Olaplex sold a single patented molecule — a bond-builder that literally repairs damaged hair — and it launched through salons, so the first people selling it were the professionals customers already trust. A numbered product system (Nº.0 through Nº.10) turned that credibility into a collectible routine, and the brand IPO'd at a roughly $15 billion valuation with margins most companies only dream of.
By the end you'll have the seven plays behind owning a patented ingredient and letting the experts sell it — each with a "steal this," plus the cautionary half most breakdowns skip.
The receipts — a rise, and a cliff
Public filings · annual revenueThey didn't sell a product. They sold a molecule.
Founded in 2014 by Dean Christal, Olaplex commercialized a patented bond-building chemistry that repairs the broken disulfide bonds in damaged hair — genuinely novel science with a mouthful of a name (bis-aminopropyl diglycol dimaleate). Crucially, they launched it professional-first: colorists and stylists used it in the chair, so the product arrived with built-in expert endorsement before it ever hit a consumer's cart.
Then they made it a system — Nº.0 through Nº.10 — so customers collected steps like a regimen, and rode a wave of TikTok before-and-afters that made Nº.3 a phenomenon. Olaplex IPO'd in 2021 at a ~$15B valuation with 60%+ EBITDA margins. And then the cliff: as L'Oréal, K18 and a flood of "bond-builders" arrived and the hype cooled, revenue slid from its ~$704M peak.
"Don't sell a bottle. Sell a molecule no one else is allowed to make."The Olaplex operating principle
Their storefront, captured live.
Seven plays every challenger brand should copy.
Own a patented molecule, not a category
Olaplex's bond-builder is intellectual property competitors literally cannot copy. That patent is a real, legal moat — and a story no shampoo brand can tell. A defensible mechanism beats a marketing claim every time.
Build on a patented or genuinely proprietary mechanism where you can. A moat you can defend in court is worth more than any ad budget.
Let the experts sell it first
Olaplex launched salon-only, so stylists — the people customers already trust with their hair — became the sales force and the credibility. Then it rode that trust to retail. A pro's recommendation converts better than any ad.
Seed the professionals your customer already believes, launch through them, then expand to consumer. Borrowed expertise is the fastest credibility.
Number your line into a system
Nº.0 through Nº.10 turns individual products into a set to complete. Numbering makes the routine legible and nudges customers to collect the next step.
Give your line a system — numbers, steps, stages. A legible regimen drives cross-purchase and makes the whole catalog feel essential.
Make the science the brand
"Bond-building," patented tech, dramatic before-and-afters — Olaplex leads with a credible, named mechanism. In beauty, a believable "why it works" is what unlocks premium pricing.
Lead with a specific, named mechanism and visible proof. People pay a premium for a product they understand and believe.
Bridge professional to consumer
The same molecule sells in the salon, on DTC, and on retail shelves — credibility flowing from one channel to the next. The dual channel multiplies reach and trust.
Run a pro-and-consumer dual channel when you can. Expert use in one channel validates the product in all the others.
Feed the virality when it hits
TikTok before-and-afters turned Nº.3 into a viral phenomenon; Olaplex leaned in and productized the demand. Organic virality is free demand you can convert if you're ready.
When a hero product goes viral, pour fuel on it — content, supply, bundles. Be ready to catch the wave, because it won't wait.
Protect margin with a focused hero
A tight, patented, high-margin line delivered 60%+ EBITDA. Depth on a few hero SKUs funded the whole brand.
Resist catalog sprawl. A focused set of high-margin heroes is more profitable and more defensible than a hundred me-too products.
The part most breakdowns skip…
A patent expires. A trend moves. The cliff is real.
Be clear-eyed — Olaplex is the cautionary half of its own playbook. After IPO'ing at ~$15B, revenue slid from a ~$704M peak toward ~$458M as L'Oréal, K18 and a wave of "bond-builder" competitors arrived and the TikTok hype cooled. A patented molecule is a moat until the patent, the trend, or the novelty fades — and a brand over-indexed on one hero SKU and one viral moment is dangerously exposed when either moves. Own the science, but keep innovating the line, refreshing the demand, and diversifying beyond the one product that made you, before the cliff finds you.
Tear off this page.
The Olaplex playbook on one screen.
Own the molecule, let the pros sell it. Fluid runs it.
A defensible mechanism, expert-first distribution, a legible system, and the discipline to keep innovating before the cliff — every play here is an operating-system problem. That's what we build.